-
1 Comment
Guangdong Zhongsheng Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 14.3% below its 200 day moving average.
From a valuation standpoint, the stock is 64.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
Guangdong Zhongsheng Pharmaceutical Co., Ltd's total revenue sank by 14.3% to $525M since the same quarter in the previous year.
Its net income has increased by 65.5% to $110M since the same quarter in the previous year.
Finally, its free cash flow fell by 20.3% to $34M since the same quarter in the previous year.
Based on the above factors, Guangdong Zhongsheng Pharmaceutical Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| ISIN | CNE100000HW4 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | 1.7% |
|---|---|
| Market Cap | 10B |
| Beta | 0.67 |
| PE Ratio | 71.19 |
| Target Price | 7.49 |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceuticals in China. The company offers Chinese and chemical medicines, raw materials, and intermediates. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. Guangdong Zhongsheng Pharmaceutical Co., Ltd. is based in Dongguan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002317.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
